Drägerwerk AG & Co. KGaA (FRA:DRW3)

Germany flag Germany · Delayed Price · Currency is EUR
67.60
+0.50 (0.75%)
Last updated: Aug 8, 2025
48.25%
Market Cap 1.16B
Revenue (ttm) 3.36B
Net Income (ttm) 99.86M
Shares Out n/a
EPS (ttm) 5.32
PE Ratio 11.59
Forward PE 10.20
Dividend 2.03 (3.00%)
Ex-Dividend Date May 12, 2025
Volume 9,708
Average Volume 13,105
Open 66.70
Previous Close 67.10
Day's Range 66.50 - 67.60
52-Week Range 42.20 - 73.10
Beta n/a
RSI 52.19
Earnings Date Jul 29, 2025

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departmen... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 1889
Employees 16,585
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol DRW3
Full Company Profile

Financial Performance

In 2024, Drägerwerk AG & Co. KGaA's revenue was 3.37 billion, a decrease of -0.08% compared to the previous year's 3.37 billion. Earnings were 124.41 million, an increase of 12.65%.

Financial Statements

News

Draegerwerk: Record Demand Surge in Early 2025 Orders!

Drägerwerk AG & Co. KGaA has marked a milestone with a surge in order intake, showcasing its robust market presence and strategic growth trajectory. The company reported its highest demand in five yea...

16 days ago - Wallstreet:Online

EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Half Year Report/Half Year Results Drägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years ...

16 days ago - Wallstreet:Online

Drägerwerk: H1 2025 Earnings Dip, Orders Surge, Forecast Steady

Drägerwerk AG & Co. KGaA navigates a challenging financial landscape, reporting a dip in EBIT yet celebrating a robust order intake surge in the first half of 2025. Jetzt den vollständigen Artikel les...

4 weeks ago - Wallstreet:Online

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2025: Earnings positive but below prior year – net sales stable – significant increase in order intake – forecast confirmed

EQS-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Forecast Drägerwerk AG & Co. KGaA: Preliminary figures H1 2025: Earnings positive but below prior year – net sales stable – sign...

4 weeks ago - Wallstreet:Online

EQS-AFR: Drägerwerk AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: Drägerwerk AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements Drägerwerk AG & Co. KGaA: Preliminary announcement of the ...

5 weeks ago - Wallstreet:Online

Drägerwerk AG & Co KGaA (DGWPF) Q1 2025 Earnings Call Transcript

Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Q1 2025 Results Conference Call April 30, 2025 8:00 AM ET Company Participants Nikolaus Hammerschmidt - IR Tom Fischler - IR Stefan Dräger - Chief Executive Offic...

3 months ago - Seeking Alpha

Drägerwerk AG & Co KGaA (DGWPF) Full Year 2024 Earnings Call Transcript

Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Full Year 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Stefan Dräger – Chief Executive Officer Gert-Hartwig Lescow – Chief Financi...

4 months ago - Seeking Alpha